Tacrolimus and Eschar - a phase IV clinical study of FDA data

Summary:

Eschar is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are male, 60+ old, also take Ciclosporin, and have Aplastic anemia.

The phase IV clinical study analyzes which people have Eschar when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Eschar?

Eschar (dead tissue that falls off (sheds) from healthy skin) is found to be associated with 156 drugs and 333 conditions by eHealthMe. Check the latest studies of Eschar.

On Jul, 15, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 28 people (0.02%) have Eschar.

Among these 28 people:

What is the gender of people who have Eschar when taking Tacrolimus? *

female: 18.52 %
male: 81.48 %

What is the age of people who have Eschar when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

What are other side effects people have besides Eschar? *

Rashes (redness): 10 people, 35.71%
Skin Necrosis (skin damage): 9 people, 32.14%
Microsporidia Infection (infection with microsporidia): 8 people, 28.57%
Thrombosis (formation of a blood clot inside a blood vessel): 8 people, 28.57%
Sinusitis (inflammation of sinus): 8 people, 28.57%
Pneumonia Fungal: 8 people, 28.57%
Pneumonia Influenzal (the flu with pneumonia): 7 people, 25.00%
Atypical Mycobacterial Pneumonia (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis): 7 people, 25.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 25.00%
Tongue Ulceration (ulcers on tongue): 7 people, 25.00%

What are the existing conditions these people have? *

Aplastic Anemia: 8 people, 28.57%
Immunodeficiency Disorders: 2 people, 7.14%
Thrombocytopenia (decrease of platelets in blood): 1 person, 3.57%
Sinusitis Aspergillus (a disease in which fungal debris and mucus build up in the sinuses): 1 person, 3.57%
Pneumonia: 1 person, 3.57%
Pain: 1 person, 3.57%
Mycobacterial Infection: 1 person, 3.57%
Lymphoproliferative Disorder (a medical condition in which the immune system makes too many white blood cells): 1 person, 3.57%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 3.57%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Eschar?

- Check whether Eschar is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,160 reports)

Eschar treatments and more:

Eschar (989 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eschar:

Eschar (156 drugs)

Browse all the conditions that are associated with Eschar:

Eschar (333 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.